Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: Utility of p16 status

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 11, 2009, Pages 1126-1132

  Shonka Jr , David C ^a   Shoushtari, Asal N ^b   Thomas, Christopher Y ^b   Moskaluk, Christopher ^b   Read, Paul W ^b   Reibel, James F ^a   Levine, Paul A ^a   Jameson, Mark J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P16;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CERVICAL LYMPH NODE; DIAGNOSTIC IMAGING; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MINIMAL RESIDUAL DISEASE; NECK DISSECTION; OROPHARYNX CANCER; OROPHARYNX CARCINOMA; PATIENT IDENTIFICATION; PREDICTION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SMOKING; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; WART VIRUS;

BIOPSY; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM PROTEINS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 73249117375     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2009.153     Document Type: Article

References (23)

1. Clayman GL, Johnson CJ II, Morrison W, Ginsberg L, Lippman SM. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg. 2001;127(2):135-139.
2. Lango MN, Andrews GA, Ahmad S, et al. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head Neck. 2009;31(3):328-337.
3. Goguen LA, Posner MR, Tishler RB, et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132(5):526-531.
4. Simon C, Goepfert H, Rosenthal DI, et al. Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol. 2006;263(4):313-318.
5. Boyd TS, Harari PM, Tannehill SP, et al. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck. 1998;20(2): 132-137.
6. Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120(8):1731-1738.
7. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV titer, bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26(19):3128-3137.
8. Chen B, van den Brekel MW, Buschers W, Balm AJ, van Velthuysen ML. Validation of tissue array technology in head and neck squamous cell carcinoma. Head Neck. 2003;25(11):922-930.
9. Weinberger PM, Yu Z, Haffty BG, et al. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res. 2004;10(17): 5684-5691.
10. Kumar B, Cordell KG, Lee JS, et al. Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys. 2007;69(2)(suppl):S109-S111.
11. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24(5):736-747.
12. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24(36):5630-5636.
13. Aebersold DM, Froehlich SC, Jonczy M, et al. Expression of transforming growth factor-alpha, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy. Radiother Oncol. 2002;63(3):275-283.
14. Laimer K, Spizzo G, Gastl G, et al. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol. 2007;43(2):193-198.
15. Doweck I, Robbins KT, Mendenhall WM, Hinerman RW, Morris C, Amdur R. Neck level-specific nodal metastases in oropharyngeal cancer: is there a role for selective neck dissection after definitive radiation therapy? Head Neck. 2003; 25(11):960-967.
16. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combinedmodality therapy of patients with locoregionally advanced head and neck cancer. Head Neck. 2004;26(5):447-455.
17. de Bree R, Putten LV, Brouwer J, Castelijns JA, Hoekstra OS, Leemans CR. Detection of locoregional recurrent head and neck cancer after (chemo) radiotherapy using modern imaging. Oral Oncol. 2009;45(4-5):386-393.
18. Pellitteri PK, Ferlito A, Rinaldo A, et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck. 2006;28(2):166-175.
19. Batstone MD, Scott B, Lowe D, Rogers SN. Marginal mandibular nerve injury during neck dissection and its impact on patient perception of appearance. Head Neck. 2009;31(5):673-678.
20. Remmler D, Byers R, Scheetz J, et al. A prospective study of shoulder disability resulting from radical and modified neck dissections. Head Neck Surg. 1986; 8(4):280-286.
21. Luan XW, Mao C, Yu GY, Guo CB, Huang MX, Ma DQ. The impacts of various types of neck dissection on postoperative shoulder function for patients with oral squamous cell carcinoma [in Chinese]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2006; 41(5):287-290.
22. Laverick S, Lowe D, Brown JS, Vaughan ED, Rogers SN. The impact of neck dissection on health-related quality of life. Arch Otolaryngol Head Neck Surg. 2004; 130(2):149-154.
23. Wenzel S, Sagowski C, Kehrl W, Metternich FU. The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol. 2004;261(5):270-275.